IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel
FY2000 Appropriations: NIH Gets $17.9 Billion, A 15% Increase, In Final Budget Agreement; $3 billion to Be Delayed
Letter to the Editor: A Victory for Research, But Real Work Is Ahead
Commentary: NCI’s Budge Proposal ForFY2001 Offers A Blueprint for Research
Science Policy: Second-Hand Smoke Linked To Lung Cancer, Other Health Effects
Funding Opportunities: RFA Available: Teams For Molecular Target Assessment
In Brief: Paul Van Nevel, Director Of NCI Communications, To Retire At Year’s End
Trending Stories
- Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor?
- Jeffrey Weber on his career, mentors: “Never ever ever ever blow your cool.”
- NCI-designated Basic Laboratory Cancer Centers get research done—efficiently
- ODAC votes decisively in support of PD-L1 expression as predictive biomarker for checkpoint inhibitors
Vote may lead to rollback of some indications held by BMS and Merck - Tom Lynch reflects on discovery of the EGFR mutations’ role in lung cancer
- Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72